Fall 2014 HIV Update

September 5-November 6, 2014; Washington, DC; Philadelphia, Pennsylvania; Glasgow, Scotland, United Kingdom
In this interactive Expert Analysis, Joseph J. Eron, Jr., MD, and Jürgen K. Rockstroh, MD, provide an in-depth discussion of the most clinically relevant new data on management of patients with HIV infection that were presented at a series of fall 2014 medical conferences.
Joseph J. Eron, Jr., MD
Jürgen K. Rockstroh, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits
Released: January 20, 2015 Expiration: January 20, 2016

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Integrate new data from observational studies and clinical trials when deciding when to start therapy, both for HIV treatment and HIV prevention
  • Devise management strategies based on the results of recent clinical studies of antiretroviral agents in treatment-naive and treatment-experienced patients
  • Apply best practices for the prevention and management of adverse events associated with HIV, antiretroviral therapy, and comorbidities
  • Provide patient care that appropriately reflects the latest findings regarding the epidemiology and clinical management of coinfections and opportunistic infections

Acknowledgements

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Educational grant provided by:
Gilead Sciences

Information on this Educational Activity

Disclosure of Conflicts of Interest

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Joseph J. Eron, Jr., MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Joseph J. Eron, Jr., MD, has disclosed that he has received consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV, Merck, Tibotec/Janssen, and Tobira; has served on data and safety monitoring boards for Vertex; and has received funds for research support from GlaxoSmithKline/ViiV.
Jürgen K. Rockstroh, MD

Professor of Medicine
University of Bonn
Bonn, Germany

Jürgen K. Rockstroh, MD, has disclosed that he has received consulting fees from AbbVie, Bionor, Bristol-Myers Squibb, Boehringer Ingelheim, Gilead Sciences, Janssen, Merck, Tibotec, Tobira, and ViiV and funds for research support from Gilead Sciences.

Staff

Jennifer M. Blanchette, PhD

Associate Managing Editor

Jennifer M. Blanchette, PhD, has no significant financial relationships to disclose.
Edward King, MA

Chief Innovation Officer

Edward King, MA, has no significant financial relationships to disclose.
Kiran Mir-Hudgeons, PhD

Clinical Editor

Kiran Mir-Hudgeons, PhD, has no significant financial relationships to disclose.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no significant financial relationships to disclose.
Heather Stieglitz, PhD

Editorial Contributor

Heather Stieglitz, PhD, has no significant financial relationships to disclose.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Charles E. Willis, Director of Continuing Education from the Annenberg Center for Health Sciences at Eisenhower consults for Pfizer, Inc.; Amanda Sewell, MBA, Manager of Continuing Education, Debbie Price, Database Administrative Secretary, and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This activity is intended for physicians and other healthcare professionals involved in the care of HIV-infected patients.

Goal

The goal of this activity is to improve participants’ competence in translating the most clinically significant and relevant data from ICAAC 2014, IDWeek 2014, and Glasgow 2014 into practical management strategies for HIV-infected patients.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 20, 2015, through January 20, 2016:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

CCO downloadable slides on new HIV data from IAS 2019: PrEP, first-line and switch options, NTD risk with ART at conception, and investigational drugs

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Paul E. Sax, MD
Released: August 15, 2019

Jonathan Appelbaum, MD, FACP, AAHIVS, provides expert commentary on the challenges with care coordination for older patients living with HIV

Jonathan Appelbaum, MD, FACP, AAHIVS Released: August 15, 2019

Free downloadable slides on HIV treatment and prevention highlights from IAS 2019 chosen by expert faculty, reported by Clinical Care Options

Brenda E. Crabtree Ramírez, MD Anton L. Pozniak, MD, FRCP Released: August 2, 2019

Download this slideset from CCO with updated analysis from the Tsepamo study of NTD prevalence with DTG vs non-DTG ART, as reported at IAS 2019

Released: July 24, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?